Replies to post #130569 on Biotech Values

[mcbio]

ACHN had $90M of cash as of 9/30/11:

Looks like ACHN has roughly two years of cash remaining if they roughly maintain this burn going forward. Separately, I think it will be interesting to compare the upcoming Phase 2 ACH-1625 data (expected by the end of the year) to that of Medivir's TMC435.